| Literature DB >> 33097276 |
Anna J Moyer1, Katheleen Gardiner2, Roger H Reeves3.
Abstract
Human chromosome 21 (Hsa21) contains more than 500 genes, making trisomy 21 one of the most complex genetic perturbations compatible with life. The ultimate goal of Down syndrome (DS) research is to design therapies that improve quality of life for individuals with DS by understanding which subsets of Hsa21 genes contribute to DS-associated phenotypes throughout the lifetime. However, the complexity of DS pathogenesis has made developing appropriate animal models an ongoing challenge. Here, we examine lessons learned from a variety of model systems, including yeast, nematode, fruit fly, and zebrafish, and discuss emerging methods for creating murine models that better reflect the genetic basis of trisomy 21.Entities:
Keywords: Down syndrome; aneuploidy; complex disease; disease models; model organisms; trisomy 21
Year: 2020 PMID: 33097276 DOI: 10.1016/j.tig.2020.09.017
Source DB: PubMed Journal: Trends Genet ISSN: 0168-9525 Impact factor: 11.639